JANX
Janux Therapeutics, Inc.Company with tickers: JANX
CIK
1817713
CUSIP
47103J105
Shares Outstanding
60,984,354
Website
https://www.januxrx.com
Investor Relations
https://investors.januxrx.com/overview/default.aspx
13F Activity (30d)
9 filings
8 filers
Weekly off-exchange (dark pool / OTC) trading volume reported to FINRA under its OTC/ATS Transparency data. ATS volume is executed on alternating trading systems (dark pools); non-ATS OTC is other over-the-counter dealer volume. The off-exchange share is total off-exchange volume as a percentage of consolidated weekly trading volume for the same Monday–Friday week.
Off-Exchange Volume History
| Week Start | ATS Volume | Non-ATS OTC Volume | Total Off-Exchange | % of FINRA Weekly Volume |
|---|---|---|---|---|
| 2026-05-04 | 1,059,618 | 723,570 | 1,783,188 | 47.5% |
| 2026-04-27 | 961,527 | 611,972 | 1,573,499 | 38.2% |
| 2026-04-20 | 1,397,108 | 1,366,428 | 2,763,536 | 52.3% |
| 2026-04-13 | 798,697 | 763,678 | 1,562,375 | 39.7% |
| 2026-04-06 | 1,015,019 | 570,215 | 1,585,234 | 39.6% |
| 2026-03-30 | 926,573 | 602,323 | 1,528,896 | 49.7% |
| 2026-03-23 | 1,385,522 | 835,408 | 2,220,930 | 37.9% |
| 2026-03-16 | 1,214,500 | 2,421,745 | 3,636,245 | 39.2% |
| 2026-03-09 | 899,119 | 630,630 | 1,529,749 | 37.3% |
| 2026-03-02 | 903,931 | 667,003 | 1,570,934 | 36.5% |
| 2026-02-23 | 806,256 | 824,807 | 1,631,063 | 40.6% |
| 2026-02-16 | 777,043 | 623,081 | 1,400,124 | 37.3% |
| 2026-02-09 | 1,561,036 | 759,579 | 2,320,615 | 44.8% |
| 2026-02-02 | 1,570,035 | 1,886,317 | 3,456,352 | 39.6% |
| 2026-01-26 | 1,254,148 | 1,195,717 | 2,449,865 | 41.8% |
| 2026-01-19 | 2,215,063 | 3,541,784 | 5,756,847 | 49.7% |
| 2026-01-12 | 1,352,847 | 1,263,843 | 2,616,690 | 38.4% |
| 2026-01-05 | 1,951,666 | 2,060,045 | 4,011,711 | 47.8% |
| 2025-12-29 | 1,431,982 | 1,425,638 | 2,857,620 | 43.2% |
| 2025-12-22 | 2,398,669 | 1,417,525 | 3,816,194 | 53.3% |
Showing 1–20 of 20 weeks